Taurine Counteracts Oxidative Stress and Nerve Growth Factor Deficit in Early Experimental Diabetic Neuropathy
- 1 November 2001
- journal article
- research article
- Published by Elsevier in Experimental Neurology
- Vol. 172 (1) , 211-219
- https://doi.org/10.1006/exnr.2001.7789
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Depletion of Taurine in Experimental Diabetic Neuropathy: Implications for Nerve Metabolic, Vascular, and Functional DeficitsExperimental Neurology, 2001
- Hyperalgesia Mediated By Spinal Prostaglandin E 2 And Signalling Through The P38 Pathway In Diabetic RatsJournal of the Peripheral Nervous System, 2000
- Ceramide selectively inhibits apoptosis-associated events in NGF-deprived sympathetic neuronsCell Death & Differentiation, 2000
- Impact of oxidative stress on signal transduction control by phosphotyrosine phosphatases.Environmental Health Perspectives, 1998
- Therapeutic Effects of Aldose Reductase Inhibitor on Experimental Diabetic Neuropathy through Synthesis/Secretion of Nerve Growth FactorExperimental Neurology, 1998
- An essential role of NFκB in tyrosine kinase signaling of p38 MAP kinase regulation of myocardial adaptation to ischemiaFEBS Letters, 1998
- Effects of the sulphydryl donor N‐acetyl‐L‐cysteine on nerve conduction, perfusion, maturation and regeneration following freeze damage in diabetic ratsEuropean Journal of Clinical Investigation, 1996
- Glycated Cu,Zn-Superoxide Dismutase in Rat lenses: Evidence for the Presence of Fragmentationin VivoBiochemical and Biophysical Research Communications, 1996
- Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slicesFree Radical Biology & Medicine, 1995
- Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents.Journal of Clinical Investigation, 1995